157 related articles for article (PubMed ID: 24414613)
41. Radiological features of triple-negative breast cancers (73 cases).
Boisserie-Lacroix M; Mac Grogan G; Debled M; Ferron S; Asad-Syed M; Brouste V; Mathoulin-Pelissier S; Hurtevent-Labrot G
Diagn Interv Imaging; 2012 Mar; 93(3):183-90. PubMed ID: 22421282
[TBL] [Abstract][Full Text] [Related]
42. Development of a carcinoma in situ in a fibroadenoma: color Doppler sonographic demonstration.
Tiu CM; Chou YH; Chiou SY; Hsu CY; Chen SP; Chiang HR; Lai CR; Tseng LM; Wang HK; Chiou HJ
J Ultrasound Med; 2006 Oct; 25(10):1335-8. PubMed ID: 16998108
[No Abstract] [Full Text] [Related]
43. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.
Tomonari M; Shimada M; Nakada Y; Yamamoto I; Itoh M; Koike Y; Kobayashi A; Miki J; Yamada H; Kimura T; Saito S; Sugano K; Sekine S; Yamamoto H; Asahina A; Yokoo T
BMC Nephrol; 2019 Oct; 20(1):394. PubMed ID: 31664942
[TBL] [Abstract][Full Text] [Related]
44. S1-Guideline Sebaceous Carcinoma.
Utikal J; Nagel P; Müller V; Becker JC; Dippel E; Frisman A; Gschnell M; Griewank K; Hadaschik E; Helbig D; Hillen U; Leiter U; Pföhler C; Krönig L; Ziemer M; Ugurel S
J Dtsch Dermatol Ges; 2024 May; 22(5):730-747. PubMed ID: 38679790
[TBL] [Abstract][Full Text] [Related]
45. [Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology].
Czerwenka KF; Zeillinger R; Kury F; Manavi M; Speiser P; Peschke M; Steinhart U; Hosmann JW; Kubista E
Gynakol Rundsch; 1991; 31 Suppl 2():378-9. PubMed ID: 1686430
[No Abstract] [Full Text] [Related]
46. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
AJR Am J Roentgenol; 2003 Apr; 180(4):901-10. PubMed ID: 12646427
[TBL] [Abstract][Full Text] [Related]
47. Bilateral breast cancer in a Chinese male.
Alagaratnam TT; Ding-Ping JS; Cheng FC; Ong GB
Aust N Z J Surg; 1981 Oct; 51(5):501-2. PubMed ID: 6274288
[No Abstract] [Full Text] [Related]
48. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus.
Miller CJ; Ioffreda MD; Billingsley EM
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1546-9. PubMed ID: 15606837
[TBL] [Abstract][Full Text] [Related]
49. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
[TBL] [Abstract][Full Text] [Related]
50. Universal immunohistochemical screening of sebaceous neoplasms for Muir-Torre syndrome: Putting the cart before the horse?
Kim RH; Nagler AR; Meehan SA
J Am Acad Dermatol; 2016 Nov; 75(5):1078-1079. PubMed ID: 27745640
[No Abstract] [Full Text] [Related]
51. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
Jessup CJ; Redston M; Tilton E; Reimann JD
Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
[TBL] [Abstract][Full Text] [Related]
52. [Correlations between receptor state and various clinico-morphological parameters: evaluation of circa 2000 cases of breast tumors].
Lampertico P; Stagni F
Pathologica; 1985; 77(1049):281-97. PubMed ID: 3008068
[No Abstract] [Full Text] [Related]
53. Synchronous Ductal Carcinoma In Situ and Intravascular Large B-cell Lymphoma of the Breast.
Alakeel F; Lee E; Baird-Howell M; Easley S
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):e91-e92. PubMed ID: 28582274
[No Abstract] [Full Text] [Related]
54. [Progesterone receptors in breast cancer. Comparison of immunohistochemical with biochemical receptor analysis. Relation between hormone receptor content and growth fraction (Ki-67)].
Ronay G; Sponsel N; Merkle E; Tulusan AH
Pathologe; 1990 Jan; 11(1):4-9. PubMed ID: 2156252
[No Abstract] [Full Text] [Related]
55. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients.
Richter-Ehrenstein C; Müller S; Noske A; Schneider A
Int J Surg Pathol; 2009 Aug; 17(4):323-6. PubMed ID: 19029173
[TBL] [Abstract][Full Text] [Related]
56. Triple-negative breast cancer: histological subtypes and immunohistochemical and clinicopathological features.
Ishikawa Y; Horiguchi J; Toya H; Nakajima H; Hayashi M; Tagaya N; Takeyoshi I; Oyama T
Cancer Sci; 2011 Mar; 102(3):656-62. PubMed ID: 21214677
[TBL] [Abstract][Full Text] [Related]
57. Metastatic Prostatic Adenocarcinoma in Patient With Muir-Torre Syndrome Misdiagnosed as Metastatic Sebaceous Carcinoma: Case Report and Systematic Literature Review.
Cattelan L; Abi-Rafeh J; Brimo F; Kazan R; Redpath M; Chergui M
Am J Dermatopathol; 2020 Sep; 42(9):700-705. PubMed ID: 32568842
[TBL] [Abstract][Full Text] [Related]
58. [Morphometric correlates of the steroid receptor content in invasive ductal breast cancers].
Mattfeldt T; Neurohr W; Müller A; Klinga K
Verh Dtsch Ges Pathol; 1985; 69():350-5. PubMed ID: 3006385
[No Abstract] [Full Text] [Related]
59. A case of intracystic papillary carcinoma accompanying widespread ductal carcinoma in situ.
Amemiya T; Oda K; Satake H; Ichihara S; Sawaki A; Shimoyama Y; Nagasaka T; Kato M; Nagino M
Breast Cancer; 2007; 14(3):312-6. PubMed ID: 17690511
[TBL] [Abstract][Full Text] [Related]
60. Extraocular sebaceous carcinoma: a report of 2 cases.
Cieza-Díaz DE; Cano-Martínez N; Barchino-Ortiz L; Longo-Imedio I
Actas Dermosifiliogr; 2012 Dec; 103(10):919-22. PubMed ID: 23149052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]